SOPHARMA AD: Sopharma Financial Statement Q1 2012

opublikowano: 2012-05-02 16:20

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
SFARM_2012_Q1.zip  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 36 / 2012
Date of issue: 2012-05-02
Short name of the issuer
SOPHARMA AD
Subject
Sopharma Financial Statement Q1 2012
Official market - legal basis
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieї№ce i okresowe
Unofficial market - legal basis
Contents of the report:
Sopharma Financial Statement Q1 2012
1. Interim individual financial statement.
2. Notes to the interim financial statement.
3. Management report.
4.Additional information under art. 33, par.1, item 6 of Ordinance 2 from 17.09.2003 of Sopharma AD.
5. Insider information of facts and circumstances which have occurring in the first quarter of 2012.
Annexes
File Description
SFARM 2012 Q1.zip SFARM 2012 Q1.zip Sopharma Financial Statement Q1 2012

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-05-02 Ognian Donev Executive Director